Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Epigenetic modification after inhibition of IGF-1R signaling in human central nervous system atypical teratoid rhabdoid tumor (AT/RT).

Shim KW, Xi G, Farnell BM, Kim DS, Tsurubuchi T, Tomita T, Mayanil CS.

Childs Nerv Syst. 2013 Aug;29(8):1245-51. doi: 10.1007/s00381-013-2087-7. Epub 2013 Apr 28.

PMID:
23624780
[PubMed - indexed for MEDLINE]
2.

Structural characterization of S100A15 reveals a novel zinc coordination site among S100 proteins and altered surface chemistry with functional implications for receptor binding.

Murray JI, Tonkin ML, Whiting AL, Peng F, Farnell B, Cullen JT, Hof F, Boulanger MJ.

BMC Struct Biol. 2012 Jul 2;12:16. doi: 10.1186/1472-6807-12-16.

PMID:
22747601
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Maternal intake of folic acid and neural crest stem cells.

Mayanil CS, Ichi S, Farnell BM, Boshnjaku V, Tomita T, McLone DG.

Vitam Horm. 2011;87:143-73. doi: 10.1016/B978-0-12-386015-6.00028-7. Review.

PMID:
22127242
[PubMed - indexed for MEDLINE]
4.

A product analog bound form of 3-oxoadipate-enol-lactonase (PcaD) reveals a multifunctional role for the divergent cap domain.

Bains J, Kaufman L, Farnell B, Boulanger MJ.

J Mol Biol. 2011 Mar 11;406(5):649-58. doi: 10.1016/j.jmb.2011.01.007. Epub 2011 Jan 13. Review.

PMID:
21237173
[PubMed - indexed for MEDLINE]
5.

Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding.

West NR, Farnell B, Murray JI, Hof F, Watson PH, Boulanger MJ.

Protein Sci. 2009 Dec;18(12):2615-23. doi: 10.1002/pro.274.

PMID:
19844956
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways.

León R, Murray JI, Cragg G, Farnell B, West NR, Pace TC, Watson PH, Bohne C, Boulanger MJ, Hof F.

Biochemistry. 2009 Nov 10;48(44):10591-600. doi: 10.1021/bi901330g.

PMID:
19810752
[PubMed - indexed for MEDLINE]
7.

Cellular mechanisms of aluminium toxicity.

Crapper McLachlan DR, Farnell BJ.

Ann Ist Super Sanita. 1986;22(2):697-702. Review. No abstract available.

PMID:
3530093
[PubMed - indexed for MEDLINE]
8.

Calcium metabolism in aluminum encephalopathy.

Farnell BJ, Crapper McLachlan DR, Baimbridge K, De Boni U, Wong L, Wood PL.

Exp Neurol. 1985 Apr;88(1):68-83.

PMID:
3979517
[PubMed - indexed for MEDLINE]
9.

Aluminum inhibition of ADP-ribosylation in vivo and in vitro.

McLachlan DR, Dam TV, Farnell BJ, Lewis PN.

Neurobehav Toxicol Teratol. 1983 Nov-Dec;5(6):645-7.

PMID:
6422319
[PubMed - indexed for MEDLINE]
10.

Tuberculosis of the epididymis.

Farnell B, Thomas P.

Can Med Assoc J. 1983 Jun 1;128(11):1296-7.

PMID:
6406029
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Aluminum neurotoxicity in the absence of neurofibrillary degeneration in CA1 hippocampal pyramidal neurons in vitro.

Farnell BJ, De Boni U, Crapper McLachlan DR.

Exp Neurol. 1982 Nov;78(2):241-58. No abstract available.

PMID:
7140895
[PubMed - indexed for MEDLINE]
12.

Synaptic transmission and intracellular sodium: ionophore induced sodium loading of nerve terminals.

Charlton MP, Thompson CS, Atwood HL, Farnell B.

Neurosci Lett. 1980 Feb;16(2):193-6.

PMID:
6302573
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk